SCHEDULE OF SEGMENT REVENUE (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024
Revenues	$ 2,523	$ 1,810	$ 5,830	$ 5,060
Cost of Revenues:
Material and Labor	1,391	1,209	3,554	3,373
Other cost of revenues	268	187	807	650
Total Cost of Revenues	1,659	1,396	4,361	4,023
Research and development (R&D)
Share based compensation			9,484	7,792
Total Research and development	3,635	3,915	11,528	9,941
Selling and marketing (S&M)
Total Selling and marketing	4,392	1,472	11,314	4,154
General and administrative (G&A)
Total General and administrative	5,888	3,489	16,157	11,078
Financial Income, net;	343	572	505	1,305
Segment net Loss	(12,708)	(7,890)	(37,025)	(22,831)
Research and Development Expense [Member]
Research and development (R&D)
Payroll and Benefits	1,089	715	3,063	2,066
Share based compensation	576	644	1,889	1,795
Clinical trials	1,105	1,289	3,401	3,240
Other R&D	865	1,267	3,175	2,840
Selling and Marketing Expense [Member]
Research and development (R&D)
Payroll and Benefits	2,975	907	7,732	2,522
Share based compensation	567	277	1,379	791
Selling and marketing (S&M)
Other S&M	850	288	2,203	841
General and Administrative Expense [Member]
Research and development (R&D)
Payroll and Benefits	1,707	889	5,015	2,539
Share based compensation	2,351	1,460	6,051	4,970
General and administrative (G&A)
Other G&A	$ 1,830	$ 1,140	$ 5,091	$ 3,569